Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day.
Medpace (MEDP) closed the most recent trading day at $600.02, moving 2.13% from the previous trading session.
In the most recent trading session, Medpace (MEDP) closed at $561.65, indicating a -1.27% shift from the previous trading day.
In the latest trading session, Medpace (MEDP) closed at $568.36, marking a +1.45% move from the previous day.
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Here is how Medpace (MEDP) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Medpace (MEDP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Medpace (MEDP) came out with quarterly earnings of $3.86 per share, beating the Zacks Consensus Estimate of $3.5 per share. This compares to earnings of $3.01 per share a year ago.
Medpace (MEDP) concluded the recent trading session at $521.21, signifying a +1.34% move from its prior day's close.
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is how Medpace (MEDP) and Black Diamond (BDTX) have performed compared to their sector so far this year.
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day.